The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
2019 Calls published
The EDCTP 2019 work plan has been published. Download PDF
All 2019 calls for proposals have been published. The first calls will open on 03 June 2019.
Overview of selected EDCTP-funded clinical studies for medical interventions against poverty-related infectious diseases, 2003-2018. EDCTP succeeds in bringing together researchers and institutions in Europe and Africa.
ASAAP paediatric malaria treatment study kicks off in Ghana
The ASAAP project – a multi-country, multi-site clinical study to evaluate a new malaria triple therapy for children – has its kick-off meeting today in Accra, Ghana. The project is led and coordinated by Dr Oumou Maiga-Ascofaré of the Kumasi Centre…
EDCTP malaria portfolio: large investments in treatment and vaccines
The World Malaria Report 2018 states that after an unprecedented period of success in global malaria control, progress has stalled. Data from 2015–2017 show no significant progress in reducing global malaria cases. In 2017 there were still an estimated 219…